Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Biol Trace Elem Res ; 96(1-3): 109-15, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14716089

RESUMO

This study was designed to measure the effects of iron supplementation on respiratory burst in iron-deficient anemia. The performance of neutrophils was evaluated by measuring the activity of NADPH oxidase in 18 patients with iron-deficient anemia before and after body iron stores are saturated. The activity of NADPH oxidase was significantly lower in pretreatment patients relative to controls (p<0.05). The activity increased after iron supplementation to levels that had no significant differences relative to controls.


Assuntos
Anemia Ferropriva/enzimologia , NADPH Oxidases/metabolismo , Neutrófilos/enzimologia , Anemia Ferropriva/imunologia , Atividade Bactericida do Sangue/imunologia , Suplementos Nutricionais , Humanos , Ferro/administração & dosagem , Ferro/farmacologia , Fagocitose/imunologia , Espectrometria de Fluorescência , Estatísticas não Paramétricas
2.
Biol Trace Elem Res ; 96(1-3): 117-23, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14716090

RESUMO

This study was designed to measure the effect of iron supplementation on antioxidant status in iron-deficient anemia, including the time for hemoglobin normalization and at the time of filling of iron body stores. The extent of plasma lipid peroxidation was evaluated by measuring the levels of malondialdehyde and glutathione peroxidase (GSH-Px), and the activities of superoxide dismutase (SOD) and catalase in 63 patients with iron-deficiency anemia before and after 6 wk of iron supplementation and at the time when body iron stores are saturated. After 6 wk of iron supplementation, a significant decrease of oxidative stress was observed in the treated subjects relative to controls (p<0.05). No significant differences existed between treated patients at 6 wk and at the end of the study. The erythrocyte levels of catalase, SOD, and GSH-Px were significantly lower in treated patients relative to controls (p<0.05). These levels increased after 6 wk of supplementation (p<0.05) and showed no significant differences with those at the end of the study.


Assuntos
Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/metabolismo , Antioxidantes/metabolismo , Ferro/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Anemia Ferropriva/enzimologia , Estudos de Casos e Controles , Catalase/sangue , Suplementos Nutricionais , Eritrócitos/enzimologia , Glutationa Peroxidase/sangue , Humanos , Ferro/administração & dosagem , Ferro/uso terapêutico , Estudos Longitudinais , Malondialdeído/sangue , Superóxido Dismutase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA